75
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy

, , , , , , , , & show all
Pages 1567-1577 | Published online: 27 Aug 2018

References

  • KashiwagiKChanges in trend of newly prescribed anti-glaucoma medications in recent nine years in a Japanese local communityOpen Ophthalmol J2010471120556196
  • GurwitzJHGlynnRJMonaneMTreatment for glaucoma: adherence by the elderlyAm J Public Health19938357117168484454
  • RobinALNovackGDCovertDWCrockettRSMarcicTSAdherence in glaucoma: objective measurements of once-daily and adjunctive medication useAm J Ophthalmol2007144453354017686450
  • FriedmanDSOkekeCOJampelHDRisk factors for poor adherence to eyedrops in electronically monitored patients with glaucomaOphthalmology200911661097110519376591
  • FriedmanDSQuigleyHAGelbLUsing pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS)Invest Ophthalmol Vis Sci200748115052505717962457
  • DjafariFLeskMRHarasymowyczPJDesjardinsDLachaineJDeterminants of adherence to glaucoma medical therapy in a long-term patient populationJ Glaucoma200918323824319295380
  • OkekeCOQuigleyHAJampelHDAdherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid studyOphthalmology2009116219119919084273
  • OkekeCOQuigleyHAJampelHDInterventions improve poor adherence with once daily glaucoma medications in electronically monitored patientsOphthalmology2009116122286229319815286
  • Cohen CastelOKeinan-BokerLGeyerOMilmanUKarkabiKFactors associated with adherence to glaucoma pharmacotherapy in the primary care settingFam Pract201431445346124927725
  • TakagiYOsakiHYamashitaTKaiYProspective observational post-marketing study of Tafluprost 0.0015%/Timolol 0.5% combination ophthalmic solution for glaucoma and ocular hypertension: short-term efficacy and safetyOphthalmol Ther20165219120627492380
  • DenisPTravoprost/timolol fixed combination in the management of open-angle glaucoma: a clinical reviewExpert Opin Pharmacother201112346347121254951
  • PfeifferNScherzerMLMaierHSafety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapyClin Ophthalmol2010445946620505839
  • MandićZNovak-LausKBojićLSafety and efficacy of monotherapy change to fixed combination (travoprost 0.004%/timolol 0.5%) in 6 months follow up periodActa Clin Croat201049441141921830452
  • BarnebeyHSOrengo-NaniaSFlowersBEThe safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solutionAm J Ophthalmol200514011.e11.e815990081
  • HigginbothamEJFeldmanRStilesMDubinerHFixed Combination Investigative GroupLatanoprost and timolol combination therapy vs monotherapy: one-year randomized trialArch Ophthalmol2002120791592212096962
  • KashiwagiKEfficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapyJpn J Ophthalmol201256433934522581454
  • HercegMNoeckerRTravoprost/timolol fixed combinationExpert Opin Pharmacother2008961059106518377347
  • BarnebeyHSRobinALAdherence to fixed-combination versus unfixed travoprost 0.004%/timolol 0.5% for glaucoma or ocular hypertension: a randomized trialAm J Ophthalmol2017176616927993589
  • TabetRStewartWCFeldmanRKonstasAGA review of additivity to prostaglandin analogs: fixed and unfixed combinationsSurv Ophthalmol200853Suppl 1S85S9219038627
  • TsumuraTKashiwagiKSuzukiYA nationwide survey of factors influencing adherence to ocular hypotensive eyedrops in JapanInt Ophthalmol Epub2018112
  • ParkMHKangKDMoonJKorean Glaucoma Compliance Study GroupNoncompliance with glaucoma medication in Korean patients: a multicenter qualitative studyJpn J Ophthalmol2013571475623065047
  • VandenbroeckSde GeestSDobbelsFFieuwsSStalmansIZeyenTPrevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO)J Glaucoma201120741442121048510
  • CateHBhattacharyaDClarkAFordhamRHollandRBroadwayDCImproving adherence to glaucoma medication: a randomised controlled trial of a patient-centred intervention (The Norwich Adherence Glaucoma Study)BMC Ophthalmol20141413224655814
  • GrayTAFenertyCHarperRIndividualised patient care as an adjunct to standard care for promoting adherence to ocular hypotensive therapy: an exploratory randomised controlled trialEye201226340741722094303
  • DreerLEOwsleyCCampbellLGaoLWoodAGirkinCAFeasibility, patient acceptability, and preliminary efficacy of a culturally informed, health promotion program to improve glaucoma medication adherence among African Americans: “Glaucoma Management Optimism for African Americans Living with Glaucoma” (GOAL)Curr Eye Res2016411505825625187
  • LoonSCJinJJin GohMThe relationship between quality of life and adherence to medication in glaucoma patients in SingaporeJ Glaucoma2015245e36e4224248002
  • RosdahlJASwamyLStinnettSMuirKWPatient education preferences in ophthalmic carePatient Prefer Adherence2014856557424812493
  • KashiwagiKTsukaharaSImpact of patient access to Internet health records on glaucoma medication: randomized controlled trialJ Med Internet Res2014161e1524429379
  • DreerLEGirkinCMansbergerSLDeterminants of medication adherence to topical glaucoma therapyJ Glaucoma201221423424021623223
  • HermannMMPapaconstantinouDMuetherPSGeorgopoulosGDiestelhorstMAdherence with brimonidine in patients with glaucoma aware and not aware of electronic monitoringActa Ophthalmol2011894e300e30521106046
  • SleathBBlalockSCovertDThe relationship between glaucoma medication adherence, eye drop technique, and visual field defect severityOphthalmology2011118122398240221856009
  • Collaborative Normal-Tension Glaucoma Study GroupThe effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucomaAm J Ophthalmol199812644985059780094